×
About 3,092 results

ALLMedicine™ Hypophosphatemia Center

Research & Reviews  1,391 results

Hyperphosphatemia rather than hypophosphatemia indicates a poor prognosis in patients w...
https://doi.org/10.1016/j.clinbiochem.2021.01.016
Clinical Biochemistry; Wang H, Zhang L et. al.

Feb 18th, 2021 - Sepsis is the leading cause of hospitalization and death in the intensive care unit. It is vital to identify high-risk patients with poor prognosis in the early stages of sepsis. We aimed to investigate the prognostic value of serum phosphorus lev...

Hereditary Fructose Intolerance - GeneReviews® - NCBI Bookshelf
https://www.ncbi.nlm.nih.gov/books/n/gene/hfi/

Feb 17th, 2021 - Following dietary exposure to fructose, sucrose, or sorbitol, untreated hereditary fructose intolerance (HFI) is characterized by metabolic disturbances (hypoglycemia, lactic acidemia, hypophosphatemia, hyperuricemia, hypermagnesemia, hyperalanine...

Refeeding syndrome in a woman with pancreatitis: a case report.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871053
The Journal of International Medical Research; Lo Gullo A, Rifici C et. al.

Feb 4th, 2021 - Refeeding syndrome can occur in malnourished patients with acute pancreatitis who have electrolyte imbalances. Refeeding syndrome is characterized by severe electrolyte imbalances (mainly hypophosphatemia, hypomagnesemia, and hypokalemia), vitamin...

Plasma intact fibroblast growth factor 23 level is a useful tool for diagnostic approac...
https://doi.org/10.1007/s00467-020-04906-8 10.1016/j.metabol.2019.01.006 10.1038/ng1095-130 10.1016/j.metabol.2019.03.009 10.1007/s00439-009-0631-z 10.1016/j.jbspin.2019.01.012 10.1172/JCI72829 10.1016/j.bone.2012.02.135 10.1073/pnas.1402218111 10.1007/s00223-017-0307-y 10.1681/ASN.2005010052 10.1210/jc.2006-0021
Pediatric Nephrology (Berlin, Germany); Giralt M, Chocron S et. al.

Jan 25th, 2021 - Primary hypophosphatemic syndromes are a heterogeneous group of rare diseases. In recent years, fibroblast growth factor 23 (FGF23) has been postulated as a useful tool for differential diagnosis of hypophosphatemic rickets characterized by impair...

see more →

Drugs  123 results see all →

Clinicaltrials.gov  1,545 results

Ergocalciferol - ergocalciferol capsule, liquid filled-NuCare Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=492452d6-2b32-39c0-e054-00144ff8d46c

Feb 22nd, 2021 - Ergocalciferol is indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.

Hyperphosphatemia rather than hypophosphatemia indicates a poor prognosis in patients w...
https://doi.org/10.1016/j.clinbiochem.2021.01.016
Clinical Biochemistry; Wang H, Zhang L et. al.

Feb 18th, 2021 - Sepsis is the leading cause of hospitalization and death in the intensive care unit. It is vital to identify high-risk patients with poor prognosis in the early stages of sepsis. We aimed to investigate the prognostic value of serum phosphorus lev...

Hereditary Fructose Intolerance - GeneReviews® - NCBI Bookshelf
https://www.ncbi.nlm.nih.gov/books/n/gene/hfi/

Feb 17th, 2021 - Following dietary exposure to fructose, sucrose, or sorbitol, untreated hereditary fructose intolerance (HFI) is characterized by metabolic disturbances (hypoglycemia, lactic acidemia, hypophosphatemia, hyperuricemia, hypermagnesemia, hyperalanine...

Ergocalciferol - ergocalciferol capsule, liquid filled-NuCare Pharmaceuticals,Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=58b63f70-9c88-9f79-e053-2a91aa0a328c

Feb 11th, 2021 - Ergocalciferol is indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.

Refeeding syndrome in a woman with pancreatitis: a case report.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871053
The Journal of International Medical Research; Lo Gullo A, Rifici C et. al.

Feb 4th, 2021 - Refeeding syndrome can occur in malnourished patients with acute pancreatitis who have electrolyte imbalances. Refeeding syndrome is characterized by severe electrolyte imbalances (mainly hypophosphatemia, hypomagnesemia, and hypokalemia), vitamin...

see more →

News  33 results

Burosumab Is a 'Game Changer,' Effective in All Subgroups of XLH
https://www.medscape.com/viewarticle/937820

Sep 21st, 2020 - A recently approved agent, burosumab (Crysvita), was better than placebo across a range of efficacy outcomes for 14 predefined subgroups of adults with X-linked hypophosphatemia (XLH), new research shows. The authors analyzed data from the initial...

Burosumab Is a 'Game Changer,' Effective in All Subgroups of XLH
https://www.staging.medscape.com/viewarticle/937820

Sep 21st, 2020 - A recently approved agent, burosumab (Crysvita), was better than placebo across a range of efficacy outcomes for 14 predefined subgroups of adults with X-linked hypophosphatemia (XLH), new research shows. The authors analyzed data from the initial...

Burosumab Shows Sustained Efficacy in Rare Inherited Rickets
https://www.medscape.com/viewarticle/919315

Oct 1st, 2019 - ORLANDO, Florida — Burosumab (Crysvita, Ultragenyx), an anti-FGF23 monoclonal antibody, shows long-term safety and efficacy out to almost 2 years in the treatment of X-linked hypophosphatemia (XLH), a rare, inherited form of rickets, according to ...

2018 FDA-approved new drugs
https://www.mdedge.com/obgyn/article/197634/obstetrics/2018-fda-approved-new-drugs/page/0/1?channel=52

Mar 27th, 2019 - Antilipemic agents Crysvita (burosumab-twza), which has a MW of about 147,000, is a fibroblast growth factor–blocking antibody indicated for the treatment of X-linked hypophosphatemia. In pregnant cynomolgus monkeys, doses slightly higher than the.

FGF23 Inhibitor Effective in Rare Inherited Form of Rickets
https://www.staging.medscape.com/viewarticle/904089

Oct 28th, 2018 - SAN DIEGO — For adults with X-linked hypophosphatemia (XLH), a rare inherited form of rickets, a monthly dose of burosumab (Crysvita, Kyowa Hakko Kirin and Ultragenyx Pharmaceutical) can normalize phosphorous levels and enhance bone mineralization...

see more →